10-K annual report · filed Oct 23, 2026

Jabil (JBL) FY2026 10-K Annual Report

Short answer

Jabil (JBL) filed its fiscal 2026 10-K annual report with the SEC on Oct 23, 2026. It reported revenue of $36.0B (+20.6% year over year) and net income of $1.0B.

  • Top risk flagged: FDA Warning Letter, August 2026: Pharmaceutics International facility manufacturing paused pending remediation of quality-system findings

FY2026 key financial metrics · XBRL

Revenue
$36.0B
+20.6% YoY
Net income
$1.0B
+58.6% YoY
Operating margin
4.7%
+0.8 pp YoY
Gross margin
9.2%
+0.3 pp YoY
EPS (diluted)
$9.75
+64.7% YoY
ROE
64.6%
+21.2 pp YoY
Operating cash flow
$2.0B
+22.1% YoY

Source: XBRL data from the Jabil (JBL) FY2026 10-K on SEC EDGAR. USD.

Jabil FY2026 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Global engineering, supply chain, and manufacturing partner managing customers’ product lifecycles across industries
  • Segment renamed Intelligent Devices and Robotics, emphasizing automation, robotics, and more complex engineered solutions
  • AI-driven supply-chain orchestration, procurement intelligence, and employee AI capability development newly emphasized
  • $36.0 billion revenue and $1.0 billion net income, with operations across approximately 120 locations in 30 countries
  • Over 4,400 employees recognized, a 66% increase from the prior fiscal year

Management Discussion & Analysis

  • Revenue $35,954M, up 20.6% YoY, driven by Intelligent Infrastructure revenue growth of 45%
  • Gross margin 9.2% vs 8.9%, operating margin 4.7% vs 4.0%, core operating margin 5.8% vs 5.4%
  • Best segment: Intelligent Infrastructure, revenue up 45%; worst: Connected Living and Digital Commerce, revenue down 4%
  • Operating cash flow $2,002M, adjusted free cash flow $1,532M, capex $628M
  • Dividends paid $1,060M, share repurchases $1,000M, fiscal 2027 capex outlook 1.5% to 2.0% of net revenue

Risk Factors

  • FDA Warning Letter, August 2026: Pharmaceutics International facility manufacturing paused pending remediation of quality-system findings
  • China exposure: significant manufacturing, design, support, and storage operations subject to tariffs, political differences, and evolving Chinese regulations
  • Global memory component shortage: current supply-chain impact threatens production, costs, and inventory obsolescence
  • Competition from diversified electronic manufacturing service providers: greater resources, vertical capabilities, and pricing power intensify margin pressure
  • Customer concentration: reduced sales or insolvency of a major customer could materially reduce revenue and increase inventory write-offs

Generated from the filing text; verify against the original. How to read a 10-K

Other Jabil annual reports

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.